Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy
Sign Up to like & getrecommendations! Published in 2022 at "Cardiovascular Therapeutics"
DOI: 10.1155/2022/2715084
Abstract: Myocardial hypertrophy is a pathological feature of many heart diseases. This is a complex process involving all types of cells in the heart and interactions with circulating cells. This study is aimed at identifying the… read more here.
Keywords: myocardial hypertrophy; hypertrophy; peptide athycaltide; analysis ... See more keywords
Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson’s disease
Sign Up to like & getrecommendations! Published in 2020 at "ADMET and DMPK"
DOI: 10.5599/admet.854
Abstract: Parkinson’s disease (PD) is a progressive neurodegenerative disease. Levodopa in combination with amantadine has a demonstrated efficacy in motility impairment. An extensive investigation of some enzymes described to be upregulated or downregulated in PD was… read more here.
Keywords: upregulated downregulated; amantadine; disease; investigation ... See more keywords